University of California San Francisco
A UCSF team has harnessed a natural protein in bacteria to create a “pause switch” in immune cells, potentially leading to more effective and safer immune therapies for diseases such as cancer and multiple sclerosis.
Population-wide levels of HIV virus dropped substantially between 2011 and May 2012 in a rural part of southwestern Uganda, the site of two community health campaigns led by doctors at the University of California, San Francisco (UCSF), San Francisco General Hospital and Trauma Center (SFGH) and Makerere University in Kampala, Uganda.
<p>When Ramon Birnbaum, <abbr title="Doctor of Philosophy">PhD</abbr>, came to <abbr title="University of California, San Francisco">UCSF</abbr> three years ago to do his postdoctoral work on the role of genetic regulation in human disease in the lab of School of Pharmacy faculty member Nadav Ahituv, <abbr title="Doctor of Philosophy">PhD</abbr>, epilepsy was barely on his radar.</p>
<p><span>Bill and Hillary Clinton, Sharon Stone, Kathleen Sebelius, Bill Gates and Elton John are a few of the headliners to speak this week at AIDS 2012, the XIX International AIDS Conference, which runs through July 27 in Washington, D.C.</span></p>
Warner C. Greene, MD, a professor of medicine, microbiology and immunology at UCSFwho directs virology and immunology research at the UCSF-affiliated Gladstone Institutes, has joined with other global AIDS experts to release a locally affordable version of the world’s leading AIDS medical textbook.
A clinical study in a remote region of southwest Uganda has demonstrated the feasibility of using a health campaign to rapidly test a community for HIV and simultaneously offer prevention and diagnosis for a variety of other diseases in rural and resource-poor settings of sub-Saharan Africa.
In January 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease.
Recent guidelines recommending cholesterol tests for children fail to weigh health benefits against potential harms and costs, according to a new commentary authored by three physician-researchers at UCSF.
Researchers from the University of California, San Francisco (UCSF) and Makerere University in Uganda have used hair and blood samples from three-month old infants born to HIV-positive mothers to measure the uninfected babies’ exposure — both in the womb and from breast-feeding — to antiretroviral medications their mothers were taking. The results, they said, are surprising.
<p>A perspective published in the <em>New England Journal of Medicine</em> this week by professors at UCSF and the Johns Hopkins University asserts that it is now possible to begin to end the AIDS epidemic by widely and strategically applying existing tools.</p>